Chymotrypsin is secreted by the pancreas and passed into the...

Chymotrypsin is secreted by the pancreas and passed into the intestine. The optimal pH for this enzyme is $7.8 .$ If a patient's pancreas cannot manufacture chymotrypsin, would it be possible to supply it orally? What happens to chymotrypsin's activity during its passage through the gastrointestinal tract?

Key Concepts

Oral Administration of Protein Therapeutics

Delivering protein-based therapeutics orally poses significant challenges because proteins may be degraded by stomach acids and digestive enzymes before they can be absorbed intact. This degradation limits the bioavailability of the active enzyme and often necessitates alternative methods or protective formulations to ensure that sufficient functional protein reaches the target site in the body.

Gastrointestinal Environment and Enzyme Stability

The gastrointestinal tract presents varying pH environments—from the highly acidic conditions in the stomach to the more neutral or slightly alkaline conditions in the intestine. Enzymes introduced orally, especially those like chymotrypsin that have an optimal alkaline pH, can be inactivated or degraded in the acidic environment of the stomach, leading to loss of their catalytic activity before they reach the site where they normally function.

Optimal pH and Enzyme Conformation

Many enzymes, including proteases like chymotrypsin, have an optimal pH at which their three?dimensional structure is maintained for maximum catalytic efficiency. This optimal pH is crucial because deviations can lead to conformational changes that reduce activity or even cause complete denaturation, meaning that the enzyme's active site may no longer effectively bind substrates.

Transcript

Please give Ace some feedback